First in Human Study with Novel Antisense Oligonucleotide

(Mary Ann Liebert, Inc./Genetic Engineering News) A single intravenous dose of MRG-110, an anti-microRNA drug, significantly reduced miR-92a levels in the blood of healthy humans.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news